Asia Pacific Sarcopenia Treatment Market
The Asia Pacific Sarcopenia Treatment Market size was valued at US$ 696.85 Mn in 2022 and is projected to reach US$ 1,164.04 Mn by 2030, growing at a CAGR of 6.6% during 2022 - 2030.
Report Coverage
- Treatment Type: Vitamin D and Calcium Supplement, Protein Supplement, Vitamin B12 Supplement
- Distribution Channel: Pharmacies, Retail Channels, Online Channels
US$ 696.85 Mn
Market size in 2022
US$ 1,164.04 Mn
Market Size by 2030
6.6%
CAGR, 2022 - 2030
2023-2030
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Asia Pacific Sarcopenia Treatment Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Asia Pacific Sarcopenia Treatment Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Asia Pacific Sarcopenia Treatment Market Regional Analysis
6.2 Asia Pacific Sarcopenia Treatment Market Revenue 2020-2030 (US$ Million)
6.3 Asia Pacific Sarcopenia Treatment Market Forecast Analysis
7. Asia Pacific Sarcopenia Treatment Market Analysis – by Treatment Type
7.1 Vitamin D and Calcium Supplement
- 7.1.1 Overview
- 7.1.2 Vitamin D and Calcium Supplement: Asia Pacific Sarcopenia Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Protein Supplement
- 7.2.1 Overview
- 7.2.2 Protein Supplement: Asia Pacific Sarcopenia Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Vitamin B12 Supplement
- 7.3.1 Overview
- 7.3.2 Vitamin B12 Supplement: Asia Pacific Sarcopenia Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. Asia Pacific Sarcopenia Treatment Market Analysis – by Distribution Channel
8.1 Pharmacies
- 8.1.1 Overview
- 8.1.2 Pharmacies: Asia Pacific Sarcopenia Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Retail Channels
- 8.2.1 Overview
- 8.2.2 Retail Channels: Asia Pacific Sarcopenia Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 Online Channels
- 8.3.1 Overview
- 8.3.2 Online Channels: Asia Pacific Sarcopenia Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. Asia Pacific Sarcopenia Treatment Market – Asia-Pacific Analysis
9.1 Overview
9.2 Asia-Pacific- 9.2.1 Asia Pacific Sarcopenia Treatment Market Breakdown, by Key Country, 2023 and 2030 (%)
- 9.2.1.1 Asia Pacific Sarcopenia Treatment Market – Revenue and Forecast Analysis – by Country
- 9.2.1.1 China: Asia Pacific Sarcopenia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
- 9.2.1.1.1 China: Asia Pacific Sarcopenia Treatment Market Breakdown, by Treatment Type
- 9.2.1.1.2 China: Asia Pacific Sarcopenia Treatment Market Breakdown, by Distribution Channel
- 9.2.1.2 India: Asia Pacific Sarcopenia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
- 9.2.1.2.1 India: Asia Pacific Sarcopenia Treatment Market Breakdown, by Treatment Type
- 9.2.1.2.2 India: Asia Pacific Sarcopenia Treatment Market Breakdown, by Distribution Channel
- 9.2.1.3 Japan: Asia Pacific Sarcopenia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
- 9.2.1.3.1 Japan: Asia Pacific Sarcopenia Treatment Market Breakdown, by Treatment Type
- 9.2.1.3.2 Japan: Asia Pacific Sarcopenia Treatment Market Breakdown, by Distribution Channel
- 9.2.1.4 Australia: Asia Pacific Sarcopenia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
- 9.2.1.4.1 Australia: Asia Pacific Sarcopenia Treatment Market Breakdown, by Treatment Type
- 9.2.1.4.2 Australia: Asia Pacific Sarcopenia Treatment Market Breakdown, by Distribution Channel
- 9.2.1.5 Rest of Asia-Pacific : Asia Pacific Sarcopenia Treatment Market – Revenue and Forecast to 2030 (US$ Million)
- 9.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Sarcopenia Treatment Market Breakdown, by Treatment Type
- 9.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Sarcopenia Treatment Market Breakdown, by Distribution Channel
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Abbott Laboratories
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Bayer AG
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Metagenics LLC
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Nestle Health Science SA
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Novartis AG
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Pfizer Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Sanofi SA
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Amway Corp
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 GSK Plc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Access the Full A Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
